Phone: Commercial
Do Brands Have Value After Exclusivity?
AUTHOR: CMK SELECT
When a successful product is about to lose its exclusivity, and is facing incursions by generics or biosimilars, a pharmaceutical manufacturer sometimes decides to walk…CONTINUE READING
Product Launch Optimization
AUTHOR: CMK SELECT
When the FDA announced its new Breakthrough Therapy Designation in 2012, it meant that the pharma industry would be able to move new life-saving drugs…CONTINUE READING
Project Transition
AUTHOR: CMK SELECT
A major pharmaceutical company hired CMK Select to manage all of its therapeutic compounds in early development – from proof of concept to regulatory submission.…CONTINUE READING
Agency On-Boarding
AUTHOR: H. Kraft
A major pharmaceutical company hired CMK Select to manage all of its therapeutic compounds in early development, from proof of concept to regulatory submission. Upon…CONTINUE READING
Brand Management
AUTHOR: C. Gordon
A leading pharmaceutical corporation needed a defined system for selecting the right healthcare physicians (HCPs) for each requested speaking engagement, while also ensuring that those…CONTINUE READING
The Value of an Integrated Launch Plan
AUTHOR: CMK SELECT
There is only one opportunity to successfully launch a pharmaceutical brand. Brand leaders must navigate pitfalls and obstacles by planning, coordinating, and executing a comprehensive…CONTINUE READING
Ensuring Launch Success with KPIs
AUTHOR: CMK SELECT
KPIs, or key performance indicators, are critical to the success of a pharmaceutical product launch. By their very definition, KPIs are measurable values that demonstrate…CONTINUE READING
Value Pricing in the Life Sciences Industry
AUTHOR: CMK SELECT
Value pricing is taking the life sciences industry by storm, providing an opportunity to create goodwill with customers and positive brand recognition. More and…CONTINUE READING
Planning for Launch Success
AUTHOR: CMK SELECT
There are many ways to measure how successful a product launch really is. With over 60 launches under our belt in the pharmaceutical industry, at…CONTINUE READING
Five Common Barriers to Optimal Launch Trajectory (Part 2 of 2)
AUTHOR: CMK SELECT
Fifty percent of new drug launches do not achieve peak sales, with half of them missing their targeted goals by 50% or more.1 How can…CONTINUE READING
